HIV, PrEP and sexual health access in Israel

No country-level PrEP recipient value was found in the 2025 UNAIDS GAM dataset. This is not evidence of zero access; national availability and reimbursement require confirmation from the national programme. [Source: https://aidsinfo.unaids.org/dataset]

No country-specific national DoxyPEP programme was confirmed in this review. WHO's 14 July 2026 guideline conditionally recommends that DoxyPEP may be offered to men who have sex with men and transgender women as part of a comprehensive sexual health package. It prioritizes people with recent or recurrent bacterial STIs and calls for antimicrobial-resistance monitoring; the guideline does not itself establish country-level availability or reimbursement. [Source: https://www.who.int/publications/i/item/9789240124110]

• National framework: Sexuality and relationship education is delivered mainly through life-skills programmes; content and implementation vary considerably across school sectors and communities.
• Interpretation: The status summarizes the verified policy framework; it does not guarantee uniform classroom delivery.

[Sources: https://www.unesco.org/gem-report/en/peer ; https://www.who.int/news-room/fact-sheets/detail/comprehensive-sexuality-education ; https://www.bzga-whocc.de/fileadmin/user_upload/Dokumente/BZgA_IPPFEN_ComprehensiveStudyReport_Online.pdf]

• Abortion: Abortion requires approval by a statutory committee under broad legal grounds; it is not formally available solely on request.
• Contraception: EPF's 2026 contraception-policy score is 49.5%; the atlas records limited general coverage with targeted youth support.
• Interpretation: The status combines legal rules and national policy access; regional availability and individual eligibility may differ.

[Sources: https://abortion-policies.srhr.org/countries/ ; https://www.epfweb.org/sites/default/files/2026-02/CCInfoEU_A3_EN_2026_FEB22-HiRes.pdf]

• Access rule: Residents are covered by national health insurance; migrant workers generally depend on employer-arranged private insurance.
• Main barriers: Asylum seekers and undocumented migrants have limited routine public coverage and rely on emergency, municipal and NGO clinics.
• Migration measure: UN DESA estimates 2,091,569 international migrants at mid-year 2024. This is a point-in-time stock, not the number of people who arrived during 2024. The estimate is based on the foreign-born population. Refugee, asylum-seeker or refugee-like population data are incorporated where indicated by UN DESA.
• Origin definition: The origin shares below use country or area of birth for foreign-born estimates and country of citizenship for foreign-citizen estimates. They do not establish a person's nationality, ethnicity, language, reason for migration, legal status, recent-arrival status or undocumented status.
• Measurement basis: Foreign-born population + refugee/asylum adjustments (UN DESA code B R)
• Evidence note: ECDC indicators use 2024 reports: the foreign-born share is calculated only among diagnoses with known origin; late diagnosis is the country-level share with CD4 <350 cells/µL and is not migrant-specific. Data Unavailable means no sufficiently interpretable value was published; a blank is not zero. The status is an editorial comparison of legal entitlement and practical access and does not apply equally to every migrant group.